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Abstract
Background: Primary nasopharyngeal lymphoma (NPL) is a very rare tumor of Waldeyer ring (WR) lymphoid tissue.
It is challenging to differentiate lymphoma infiltration of pituitary from a pituitary adenoma, meningioma infiltration,
and other sellar lesions to plan a suitable treatment strategy. We presented for the first time a unique case of NPL with
an unusual presentation of oculomotor nerve palsy associated with pan-pituitary involvement in a diabetic patient.
Case presentation: A 64-year old diabetic woman with no previous history of malignancy presented with intermittent
diplopia for about the last nine months. Severe headache, left eye ptosis and hypoglycemic episodes were added to
her symptoms after a while. Further complaints include generalized weakness, loss of appetite, generalized musculoskeletal
pain, and 6–7 kg weight loss within six months. Her family history was unremarkable. Physical examinations of eyes
indicated left eye 3rd, 4th, and 6th nerve palsy. But, she was not anisocoric, and the pupillary reflexes were normal on both
eyes. No lymphadenopathy, organomegaly and other abnormalities were found. Magnetic resonance imaging (MRI)
showed a heterogeneous enhancement in the seller and suprasellar regions, enlargement of the stalk, parasellar dural
enhancement and thickening of the sphenoid sinus without bone erosion. Also, both cavernous sinuses were infiltrated
and both internal carotid arteries were encased by the neoplastic lesion. It suggested an infiltrative neoplastic lesion which
compressed the cranial nerves. Pituitary hormone levels assessment indicated a pan-hypopituitarism. Following
nasopharyngeal mucosal biopsy, the immunohistochemistry (IHC) findings revealed a low-grade non-Hodgkin’s B-cell
lymphoma. Systemic workup, including cerebrospinal fluid (CSF) studies, bone marrow aspiration, chest and
abdominopelvic high-resolution computed tomography (HRCT) indicated no other involvement by the lymphoma. After
chemotherapy courses, central adrenal insufficiency, partial central diabetes incipidious (CDI) and central hypothyroidism
have been resolved. To our best knowledge, we found 17 cases of NPL with cranial nerve palsy, 1 case of NPL with pan-
hypopituitarism and no NPL case with both cranial nerve palsy and pituitary dysfunction.
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Conclusions: The incidence of cranial neuropathy in patients with diabetes should not merely be attributed to diabetic
neuropathy without further evaluation.
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Background
Nasopharyngeal lymphoma (NPL) is a rare malignancy
with extranodal lymphoid proliferation [1]. NPL is classi-
fied into Hodgkin lymphoma and non-Hodgkin lymph-
oma (NHL). NHL lymphoma accounts for 86 to 90% of
all lymphoma cases [2, 3]. Lymphoid tissues of the palat-
ine tonsils, soft palate, nasopharynx, oropharyngeal wall,
and base of the tongue is known as the Waldeyer’s ring
[1]. Previous studies have indicated that less than 10–
18% of NHL cases involve the Waldeyer’s ring [1, 4],
which about 35–37% of them were at the nasopharyn-
geal site [1]. In most cases, NPL appears with nasal man-
ifestations, including epistaxis, nasal obstruction, and
purulent rhinorrhea. However, it can present with a neck
mass, headache, and B symptoms (i.e., weight loss, night
sweats, and fever), less commonly [5].
On the other hand, 10–15% of intracranial neoplasms
were attributed to pituitary tumors [6]. It has been re-
ported that pituitary adenoma and meningioma are the
most common tumors which can involve the pituitary
gland. However, it is a rare site for diffuse malignant
disease and metastasis [7]. The pituitary gland can be
involved by metastatic lesions via the skull base,
hematogenous, or meningeal spread [8]. According to a
recent systematic review, the pituitary metastases (PM)
are uncommon, accounting for 0.4% of intracranial me-
tastases [9]. Almost every cancer is reported having a
potential source for sellar metastasis. Lung and breast
neoplasms are responsible for two-thirds of PM. The fre-
quency of NHL involving the hypothalamus-pituitary
axis is < 0.5% among PM [10]. A systematic review in
2015 stated that the most common symptom among all
reported PM cases is diabetes insipidus. Anterior hypo-
pituitarism (39.66%), visual deterioration (41.38%), cra-
nial nerve palsies (41.38%) and headaches (32.76%) were
the other symptoms which were reported. As symptom-
atic PM can be closely mimic a pituitary adenoma, the
presentations of diabetes insipidus and/or cranial neu-
ropathies could suggest PM rather than pituitary aden-
oma, especially in a rapidly developed courses, and in
patients over 50 years old. Moreover, some studies have
suggested that the presence of bony erosion without
sellar enlargement indicates PM more than a pituitary
adenoma [11]. PM has a poor prognosis and the man-
agement of patients with PM is palliative. The diagnosis
of such malignancies is challenging because patients
mostly presented nonspecific signs that could over-
shadow symptoms of hypopituitarism or diabetes insipi-
dus, so the diagnosis is ultimately confirmed by
histopathology [9, 12]. Sellar masses are rarely consti-
tuted by infiltrative neoplasm (such as lymphoma), in-
flammatory and granulomatous diseases of the pituitary
[13]. Therefore, in a patient with lymphoma, it is essen-
tial to differentiate lymphoma infiltration of the pituitary
from benign lesions to plan an appropriate treatment
strategy.
Case presentation
A 64-year old woman with a history of type 2 diabetes
mellitus for more than thirty years and no previous his-
tory of malignancy presented with intermittent diplopia
for about the last nine months, especially while going
down the stairs. Diplopia was gradually increasing fre-
quency and intensity in the previous few months. During
the previous two months, the patient developed a severe
headache, left eye ptosis, and hypoglycemic episodes.
Further complaints include generalized weakness, loss of
appetite, generalized musculoskeletal pain, and 6–7 kg
weight loss within six months. Her hemoglobin A1C
levels were around 7% in prior visits. Her family history
was unremarkable.
In our initial physical examinations, she was obese
(body mass index =34 kg/m2), and her blood pressure
was 120/80 mmHg. No lymphadenopathy and organo-
megaly were found. No other abnormalities were noted
on physical examinations except for left eye ptosis (3rd,
4th, and 6th nerve palsy). But, she was not anisocoric,
and the pupillary reflexes were normal on both eyes.
The pupils were round and equal and reacted to light
consensually and directly. Visual acuity was normal in
both eyes. The other examinations of cranial nerves were
normal. Magnetic resonance imaging (MRI) of the
hypothalamus and pituitary indicated a heterogeneous
enhancement of the sellar and suprasellar regions, en-
largement of the stalk, parasellar dural enhancement
with the involvement of both cavernous sinuses and in-
ternal carotid arteries, and thickening of the sphenoid
sinus without any bone erosion. It was not possible to
differentiate between pituitary tumor and infiltrated
nasopharyngeal region. It suggested an infiltrative neo-
plastic lesion that compressed left III, IV and VI cranial
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nerves. Also, the thickening of the sphenoid sinuses and
nasopharyngeal regions was seen (Fig. 1).
Complete blood cell testing showed leukopenia and
thrombocytopenia. As per whole blood count, red blood
cell (RBC) and platelet counts were 4.69 Mil/ mm3 and
88,000/mm3, respectively. Also, white blood cell count
(WBC) was 3100/mm3 (consist of 44% lymphocytes, 45%
neutrophils, 8.7% monocyte, 1.6% eosinophil and 0.7%
basophil). Hemoglobin and hematocrit were 12.9 g/dl
and 37.6%, respectively.
To evaluate the patient for infiltrative disease, i.e.,
lymphoma, sarcoidosis, and tuberculosis, we tested
serum lactate dehydrogenase (LDH) and angiotensin-
converting enzyme (ACE) levels, which were reported in
the normal range (LDH: 353 (230–460 U/L) and ACE:
51.1(8–52 U/L)). Also, the purified protein derivative
(PPD/tuberculin) test was negative.
To rule out immunological diseases that could infiltrate
cavernous sinuses and pituitary gland area (e.g., Wegener’s
granulomatosis, Ig G4 related disease), immunologic assays
were done. All serum immunology assays except peri-
nuclear anti-neutrophil antibodies (P-ANCA or anti-MPO)
were within their reference values i.e. immunoglobulin G
(IgG): 1055 (700–1600mg/dL), Ig A: 208 (70-400mg/dL),
Ig M: 45 (40–230mg/dL), Cytoplasmic anti-neutrophil
antibodies (C-ANCA or Anti-PR3): 4.9 (Negative: < 10 U/
mL), and IgG4: 550.3 (39–864mg/L). The result of P-
ANCA was 23.5 U/mL (Negative: < 10). The bone marrow
aspiration and biopsy were performed according to bi-
cytopenia that showed cellular marrow without atypia.
Laboratory evaluation of hypothalamic and pituitary
axis revealed a pan-hypopituitarism i.e. free T4: 0.6 (0.7–
2.5 ng/dL), free T3: 0.18 (0.2–0.5 ng/dL), thyroid-
stimulating hormone (TSH): 0.47 (0.3–4.2 μIU/mL), cor-
tisol at 8 am: 3 (5–23 μg/dL), adrenocorticotrophic
hormone (ACTH): 24.78 (7.2–64 pg/mL), luteinizing
hormone (LH): 1.2 (8.2–40.8 IU/L), follicle-stimulating
hormone (FSH): 5.3 (35–153 IU/L), prolactin: 9.7 (2.1–
17.7 ng/mL), and insulin like growth factor-1 (IGF-1): 24
(33–220 ng/mL).
In cerebrospinal fluid (CSF) analyses, protein and LDH
were elevated (Table 1). CSF cytology examination
showed a few small lymphoid cells with irregular nuclei.
Pathologic findings of tissue biopsy of thickened naso-
pharyngeal mucosa reported a low-grade lymphoma.
Cell immunohistochemistry (IHC) were positive for
CD20 and Bcl-2 in most lymphoid cells (B-cells). More-
over, CD3 and CD5 were positive, and CD10 was nega-
tive in some lymphoid cells (T-cells). Also, CD-23 and
cyclin D1 were negative, and cell proliferation index Ki-
67 was about 10%. These findings revealed a low-grade
B-cell lymphoma (Fig. 2).
Chest and abdominopelvic high-resolution computed
tomography (HRCT) indicated no abnormalities and
lymphadenopathy. So we concluded that the final diag-
nosis for the current patient was a primary lymphoma
originated from the nasopharyngeal mucosa by spread-
ing the upwards areas, including both cavernous sinuses,
sellar, and suprasellar regions.
She received six courses of chemotherapy with CHOP:
cyclophosphamide, doxorubicin hydrochloride, vincris-
tine sulfate, and dexamethasone plus Rituximab. Oral
prednisolone (7.5 mg daily) and levothyroxine (50 μg
daily) were prescribed simultaneously with chemother-
apy, due to her pan-hypopituitarism. A few days after
prednisolone usage, ptosis dramatically improved. MRI
enhancement in the sellar and suprasellar regions and
both cavernous sinuses were largely eliminated after the
last chemotherapy course (Fig. 3). Besides, hematological
defects were improved significantly.
Fig. 1 Coronal and sagittal planes of Pituitary and hypothalamus magnetic resonance imaging ± Gadolinium at baseline
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One month after treatment with prednisolone, the pa-
tient complained about polyuria and nocturia. Partial
central diabetes insidious (CDI) was diagnosed based on
more than 3 l 24-h urine volume, mild hypernatremia
(Na: 147 meq/L) and low urine osmolality (urine specific
gravity was 1.005 whereas the urine specific gravity in
the first evaluation was 1.010). After chemotherapy
courses central adrenal insufficiency, partial CDI and
central hypothyroidism have been resolved.
Search strategy for literature review
We searched PubMed for articles published from Jan 1,
1990, to Aug 1, 2020, using the search terms “nasopha-
ryngeal lymphoma”, “non-Hodgkin’s lymphoma of the
nasopharynx”, “nasopharyngeal B-cell non-Hodgkin’s
lymphoma”, “nasopharyngeal Hodgkin’s disease” in com-
bination with the terms “pan-hypopituitarism”, “pituitary
dysfunction”, “cranial nerves palsy”, “multiple cranial
nerve palsy”, “oculomotor nerve palsy”, “isolated oculo-
motor nerve palsy”, “multiple cranial nerve dysfunction”,
” III cranial nerve palsy”, “IV cranial nerve palsy”, “VI
cranial nerve palsy”, “third cranial nerve palsy”,“4th cra-
nial nerve palsy”,“6th cranial nerve palsy”. Articles pub-
lished in English were included. We focused mostly on
articles from case reports or case series.
Discussion and Conclusions
We have described a woman with type 2 diabetes melli-
tus and nasopharyngeal B-cell lymphoma infiltration of
both cavernous sinuses and pituitary gland, who pre-
sented with the left eye ptosis (3rd, 4th, and 6th nerve
palsy), severe headache, and pan-hypopituitarism.
Clinical presentations in our patient (i.e., hypopituitar-
ism, headaches, and visual disturbances) could suggest
the infiltration of the pituitary gland by lymphoma,
leukemia, and metastasis to the pituitary. In our patient,
Table 1 Cerebrospinal fluid (CSF) analyses
CSF components Results Normal value
Sugar (mg/dL) 113 40–70
Protein (mg/dL) 183.8 15–45
LDH (U/L) 71 10% of the serum value (Serum level of LDH: 353 U/L)
WBC (/Cumm) 80 –
PMN (number) 5 –
MN (number) 80 –
RBC (/cumm) 60 –
CSF culture No growth –
VDRL No reactive –
MTB/NTM DNA PCR Undetectable –
LDH Lactate dehydrogenase, WBC White blood cell, PMN Polymorphonuclear leukocyte, MN mononuclear leukocyte, RBC Red blood cell, VDRL Venereal disease
research laboratory, MTB/NTM DNA PCR Mycobacterium tuberculosis / nontuberculous mycobacteria DNA polymerase chain reaction
Fig. 2 Histopathologic features of nasopharyngeal tissue biopsies: a and b H&E staining of nasopharyngeal mucosal tissue infiltrated by atypical
lymphocytes; c Positive IHC for CD20; d IHC for ki67. H&E, Hematoxylin-Eosin; IHC, Immunohistochemistry
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the left eye oculomotor nerve palsy suggested two main
differential diagnoses as diabetic cranial neuropathy or
cavernous sinuses involvement.
A comprehensive review on the management of III
nerve palsy suggested that when a patient presents with
an acute onset of unilateral limitation of an eye, the de-
fect should be categorized to “complete or partial” and
“with or without the involvement of the pupil” to come
to a diagnosis. Pupil-sparing in old patients with known
systemic vascular disease can suggest ischemic mono-
neuropathy as a common cause [14]
The adjacent cavernous sinus infiltration involving
nerve III, IV, and VI, usually induces cranial nerve palsy
in decreasing order of frequency. 6th nerve palsy is rela-
tively uncommon because it is well sheltered in the cav-
ernous sinus [7]. In diabetic neuropathy, multiple cranial
nerve palsies are extremely rare, and pupillary reflex
usually spared because the ischemic lesion is confined to
the core of the nerve and does not affect peripherally sit-
uated pupillomotor fibers [15]. Although diabetic neur-
opathy is the most common cause of third nerve palsy, it
is advisable to perform a brain MRI to exclude other
causes of oculomotor nerve palsy [16].
On the other hand, poor glycemic control or rapid
treatment of hyperglycemia could increase the risk of
diabetic neuropathy [17]. It may have an acute onset
resulting from ischemic infarction of the vasa nervorum
[18]. Diabetic neuropathy was less suggested in our pa-
tient due to well-controlled diabetes, the chronic and in-
sidious presentation of the symptoms, and multi-
neuropathy involvement.
Sato et al. stated that isolated oculomotor nerve palsy
was most frequently associated with the large B-cell
lymphoma cell type. Pupil sparing oculomotor nerve
palsy suggests infarction of the oculomotor nerve, as is
commonly observed in patients with diabetes mellitus;
despite this, there was no infarction of the oculomotor
nerve on histological examination in the reported cases
with lymphoma and isolated oculomotor palsy [19]
These findings suggest that whether the pupil is involved
or spared may depend on damage to the pupilomotor fi-
bers in the oculomotor nerve by infiltration or compres-
sion by lymphoma. Moreover, as acknowledged by
Brazis, compressive cavernous sinus lesions might spare
the pupil “because they often involve only the superior
division of the oculomotor nerve that carries no pupillo-
motor fibers, or the superior aspect of the nerve anterior
to the point where the pupillomotor fibers descend in
their course near the inferior oblique muscle” [15]
Excluding neoplastic disorders, other etiologies of mul-
tiple cranial nerve palsy include infections (e.g., Myco-
bacterium tuberculosis), inflammatory diseases (e.g.,
sarcoidosis, vasculitis, Wegener’s granulomatosis, amyl-
oidosis, connective tissue disease, rheumatoid arthritis),
vascular disease (e.g., diabetes, aneurysm, carotid artery
dissection, sickle-cell disease), bone disease (e.g., Paget’s
disease) and trauma (e.g., closed head injury) [20].
Regarding the source of the lymphoma, pituitary
lymphoma is very rare, and there is no report for extra-
sellar spreading in literature till now [21]. On the other
hand, malignancy of WR lymphoid tissue and primary
involvement of nasopharyngeal is an uncommon tumor
that includes a small part of NHL and has the potential
to infiltrate the adjacent tissues [1]. So, in this case naso-
pharyngeal lymphoma was more probable than primary
CNS lymphoma.
A few studies are reporting the clinical characteristics
of NH lymphomas [22, 23]. Hsueh et al. reported that in
35 cases of NPL during 22 years’ follow-up with the
average age of 59.6 years, WBC of 12,992/mm3, LDH of
337.7 U/L, and the meantime from initial symptoms to
diagnosis of 2.6 months, neck lymph nodes involvement
or other distant involvements were detected in less than
a third of patients at the time of diagnosis. Also, 14.3%
of the patients were presented with B symptoms. Diffuse
large B cell lymphoma was the most common patho-
logical diagnosis of nasopharyngeal (n = 17), followed by
NK/T cell lymphoma (n = 9). Extranodal marginal zone
Fig. 3 Coronal and sagittal planes of Pituitary and hypothalamus magnetic resonance imaging ± Gadolinium after completing chemotherapy
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lymphoma of mucosa-associated lymphoid tissue, mantle
cell lymphoma, and small lymphocytic lymphoma was
the other pathologic diagnoses [5]. To compare our pa-
tient with Hsueh et al. study, our patient had leukopenia
and a longer duration from initial symptoms (i.e., diplopia)
to diagnosis (about 9months) and similar age and LDH
levels. Pathological findings in our patient were compat-
ible with mantle zone lymphoma, which was one of the
lesser-known cases in NH lymphomas. Our patient’s
presentations were noteworthy due to her pituitary and
cavernous sinus involvement, while she had no remark-
able B-symptoms and nasal involvement. Unusual mani-
festations of a rare disease led to a prolonged diagnosis.
NHL of the nasopharyngeal region is usually invasive
and has a strikingly poor prognosis than other extrano-
dal lymphomas [24]. Also, localized disease and low-
grade NPL are associated with a better prognosis [22].
Moreover, B symptoms have been reported to be associ-
ated with poor prognosis [25]. Our patient suggested
having a relatively good prognosis due to her localized
and low-grade disease.
There are limited data regarding epidemiologic and
treatment outcomes of NH lymphoma [5]. The treat-
ment of localized disease (stage I, II and non-bulky dis-
ease) with activity index less than 2 and normal LDH
level is based on the CHOP regimen (3 to 4 cycles) plus
Rituximab (if CD20 positive in immunochemistry).
Based on Allam et al. study, More than 80% of patients
may be successfully treated by this regimen [22]. Our
patient responded to chemotherapy and resolved her
hematological defects.
Glucocorticoids act as a down-regulatory signal to
suppress arginine vasopressin (AVP (and corticotropin-
releasing hormone (CRH (secretion via negative feed-
back loops, respectively. In patients with hypocortiso-
lism, glucocorticoid deficiency stimulates CRH, and
therefore AVP release. So glucocorticoid replacement
could increase free water excretion and unmask the con-
comitant CDI [26] as showen in our patient. Although
pituitary dysfunction was improved in most cases,
complete recovery occurred less frequently [27]. Adrenal
insufficiency, central hypothyroidism and CDI have been
resolved in our patient.
To our best knowledge, we found 17 cases of NPL
with cranial nerve palsy, 1 case of NPL with pan-
hypopituitarism and no NPL case with both cranial
nerve palsy and pituitary dysfunction as showed in
Table 2 [28–35].
In conclusion, we presented for the first time a unique
case of NPL with an unusual presentation of oculomotor
nerve palsy associated with pan-pituitary involvement in
a diabetic patient. The incidence of cranial neuropathy
in patients with diabetes should not merely be attributed
to diabetic neuropathy without further evaluation.
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